NCT06892106

Brief Summary

The goal of this study is to investigate the role of gut microbiota, and related immune biomarkers and metabolites, in the functional recovery of spinal cord injury patients during the subacute phase. The main question it aims to answer is: How does gut microbiota dysbiosis impact functional recovery in subacute SCI patients, in a way that future targeted probiotic interventions may improve SCI outcomes?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2023

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

March 18, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 24, 2025

Completed
Last Updated

March 24, 2025

Status Verified

March 1, 2025

Enrollment Period

2.5 years

First QC Date

March 18, 2025

Last Update Submit

March 18, 2025

Conditions

Keywords

Spinal Cord InjuryRehabilitationGut MicrobiotaImmune SystemGut-Immune-CNS Axis

Outcome Measures

Primary Outcomes (3)

  • Change in intestinal microbiota

    Microbiota relative abundance of different taxonomic levels to estimate change in alpha-diversity (diversity within different samples from the same individual) and in beta-diversity (diversity between groups) from hospital admission to 1-year post-injury

    From hospital admission until to one-year post-injury

  • Change in functional independence from hospital admission to 1-year post-injury

    Change in functional independence, as measured by the Spinal Cord Independence Measure, 4th version (SCIM IV) and by Functional Independence Measure (FIM), from hospital admission to 1-year post-injury.

    From hospital admission until to one-year post-injury

  • Change in neuromotor impairment from hospital admission to 1-year post-injury

    Change in the total ASIA Impairment Scale (AIS) motor score from hospital admission to 1-year post-injury.

    From hospital admission until to one-year post-injury

Secondary Outcomes (3)

  • Change in bowel function from hospital admission to 1-year post-injury

    From hospital admission until to one-year post-injury

  • Change in immunological and inflammation biomarkers

    From hospital admission until to one-year post-injury

  • Change in gut microbiota-produced metabolites

    From hospital admission until to one-year post-injury

Study Arms (3)

Spinal cord injury patients - A or B AIS classification

Spinal cord injury patients admitted for hospitalization at Centro de Reabilitação do Norte, Unidade Local de Saúde de Gaia / Espinho, E.P.E. with A (complete) or B (sensory incomplete) classification in The American Spinal Injury Association (ASIA) Impairment Scale (AIS)

Spinal cord injury patients - C or D AIS classification

Spinal cord injury patients admitted for hospitalization at Centro de Reabilitação do Norte, Unidade Local de Saúde de Gaia / Espinho, E.P.E. with C or D (motor incomplete) classification in The American Spinal Injury Association (ASIA) Impairment Scale (AIS)

Able-bodied controls

Age, gender and body mass index matched control group of participants recruited among able-bodied personnel from Centro de Reabilitação do Norte, Unidade Local de Saúde de Gaia / Espinho, E.P.E. or their relatives, without any known CNS disease

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to Centro de Reabilitação do Norte (CRN) / Unidade Local de Saúde de Gaia e Espinho (ULSGE), between 1st of May 2021 and 16th of October 2023, following a traumatic spinal cord injury.

You may qualify if:

  • Adults (≥18 years) with traumatic spinal cord injury.
  • Injury occurred less than 6 months ago (subacute phase).
  • Any neurological level of injury (AIS A-D).

You may not qualify if:

  • Use of probiotics or immunomodulatory drugs in the last month.
  • Major gastrointestinal surgery in the last 5 years.
  • Active gastrointestinal diseases or other CNS diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Reabilitação do Norte (CRN) / Unidade Local de Saúde Gaia e Espinho (ULSGE)

Vila Nova de Gaia, Porto District, 4405 - 565 Vila Nova de Gaia, Portugal

Location

Biospecimen

Retention: SAMPLES WITH DNA

Fecal and blood samples

MeSH Terms

Conditions

Spinal Cord InjuriesImmune System Diseases

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Maria Ribeiro da Cunha, PhD

    Centro de Reabilitação do Norte (CRN) / Unidade Local de Saúde Gaia e Espinho (ULSGE))

    PRINCIPAL INVESTIGATOR
  • Sandra Vieira

    Institute of Biomedicine - Aveiro University (iBiMED-UA)

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2025

First Posted

March 24, 2025

Study Start

May 1, 2021

Primary Completion

October 16, 2023

Study Completion

October 16, 2023

Last Updated

March 24, 2025

Record last verified: 2025-03

Locations